ENGN Engene Therapeutics1.65-0.07 (-4.1%)
ENGN Engene Therapeutics1.88-6.97 (-78.8%)
Premarket Decliner
ENGN Engene Therapeutics8.85+0.96+12.2%
Premarket:2.76-6.09 (-68.8%)
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
Business WireThu, 7-May 7:00 AM